Loading…

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice

Ultrastructural reconstruction of 27 fibrillar plaques in different stages of formation and maturation was undertaken to characterize the development of fibrillar plaques in the brains of human APP(SW) transgenic mice (Tg2576). The study suggests that microglial cells are not engaged in Abeta remova...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of aging 2001-01, Vol.22 (1), p.49
Main Authors: Wegiel, J, Wang, K C, Imaki, H, Rubenstein, R, Wronska, A, Osuchowski, M, Lipinski, W J, Walker, L C, LeVine, H
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c191t-5129570f64804c64d31f51ba1e9dae6435d0a2437199949da01d01216adc796a3
cites
container_end_page
container_issue 1
container_start_page 49
container_title Neurobiology of aging
container_volume 22
creator Wegiel, J
Wang, K C
Imaki, H
Rubenstein, R
Wronska, A
Osuchowski, M
Lipinski, W J
Walker, L C
LeVine, H
description Ultrastructural reconstruction of 27 fibrillar plaques in different stages of formation and maturation was undertaken to characterize the development of fibrillar plaques in the brains of human APP(SW) transgenic mice (Tg2576). The study suggests that microglial cells are not engaged in Abeta removal and plaque degradation, but in contrast, are a driving force in plaque formation and development. Fibrillar Abeta deposition at the amyloid pole of microglial cells appears to initiate three types of neuropil response: degeneration of neurons, protective activation of astrocytes, and attraction and activation of microglial cells sustaining plaque growth. Enlargement of neuronal processes and synapses with accumulation of degenerated mitochondria, dense bodies, and Hirano-type bodies is the marker of toxic injury of neurons by fibrillar Abeta. Separation of amyloid cores from neurons and degradation of amyloid cores by cytoplasmic processes of hypertrophic astrocytes suggest the protective and defensive character of astrocytic response to fibrillar Abeta. The growth of cored plaque from a small plaque with one microglial cell with an amyloid star and a few dystrophic neurites to a large plaque formed by several dozen microglial cells seen in old mice is the effect of attraction and activation of microglial cells residing outside of the plaque perimeter. This mechanism of growth of plaques appears to be characteristic of cored plaques in transgenic mice. Other features in mouse microglial cells that are absent in human brain are clusters of vacuoles, probably of lysosomal origin. They evolve into circular cisternae and finally into large vacuoles filled with osmiophilic, amorphous material and bundles of fibrils that are poorly labeled with antibody to Abeta. Microglial cells appear to release large amounts of fibrillar Abeta and accumulate traces of fibrillar Abeta in a lysosomal pathway.
doi_str_mv 10.1016/S0197-4580(00)00181-0
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_11164276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11164276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c191t-5129570f64804c64d31f51ba1e9dae6435d0a2437199949da01d01216adc796a3</originalsourceid><addsrcrecordid>eNo9j0tLAzEURrNQbK3-BCXLdjF670wmaZal-IKChVZcljtJpkYyMzWZCv33WnysPjgfHDiMXSHcIKC8XQFqlYlyCmOACQBOMYMTNvzHA3ae0jsAKKHkGRsgohS5kkNm12-Oxy443tW88SZ22-ApcONCSJxayyn1sTOH3iXuW177KvoQKPJdoI-94-6zC_ved-3x7SO1aetab_hsuRyvXidHp7tgpzWF5C5_d8Re7u_W88ds8fzwNJ8tMoMa-6zEXJcKaimmIIwUtsC6xIrQaUtOiqK0QLkoFGqtxTcDtIA5SrJGaUnFiF3_eHf7qnF2s4u-oXjY_OUWX8KcVak</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice</title><source>Elsevier</source><creator>Wegiel, J ; Wang, K C ; Imaki, H ; Rubenstein, R ; Wronska, A ; Osuchowski, M ; Lipinski, W J ; Walker, L C ; LeVine, H</creator><creatorcontrib>Wegiel, J ; Wang, K C ; Imaki, H ; Rubenstein, R ; Wronska, A ; Osuchowski, M ; Lipinski, W J ; Walker, L C ; LeVine, H</creatorcontrib><description>Ultrastructural reconstruction of 27 fibrillar plaques in different stages of formation and maturation was undertaken to characterize the development of fibrillar plaques in the brains of human APP(SW) transgenic mice (Tg2576). The study suggests that microglial cells are not engaged in Abeta removal and plaque degradation, but in contrast, are a driving force in plaque formation and development. Fibrillar Abeta deposition at the amyloid pole of microglial cells appears to initiate three types of neuropil response: degeneration of neurons, protective activation of astrocytes, and attraction and activation of microglial cells sustaining plaque growth. Enlargement of neuronal processes and synapses with accumulation of degenerated mitochondria, dense bodies, and Hirano-type bodies is the marker of toxic injury of neurons by fibrillar Abeta. Separation of amyloid cores from neurons and degradation of amyloid cores by cytoplasmic processes of hypertrophic astrocytes suggest the protective and defensive character of astrocytic response to fibrillar Abeta. The growth of cored plaque from a small plaque with one microglial cell with an amyloid star and a few dystrophic neurites to a large plaque formed by several dozen microglial cells seen in old mice is the effect of attraction and activation of microglial cells residing outside of the plaque perimeter. This mechanism of growth of plaques appears to be characteristic of cored plaques in transgenic mice. Other features in mouse microglial cells that are absent in human brain are clusters of vacuoles, probably of lysosomal origin. They evolve into circular cisternae and finally into large vacuoles filled with osmiophilic, amorphous material and bundles of fibrils that are poorly labeled with antibody to Abeta. Microglial cells appear to release large amounts of fibrillar Abeta and accumulate traces of fibrillar Abeta in a lysosomal pathway.</description><identifier>ISSN: 0197-4580</identifier><identifier>DOI: 10.1016/S0197-4580(00)00181-0</identifier><identifier>PMID: 11164276</identifier><language>eng</language><publisher>United States</publisher><subject>Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Amyloid beta-Peptides - metabolism ; Amyloid beta-Protein Precursor - genetics ; Amyloid beta-Protein Precursor - metabolism ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Animals ; Astrocytes - metabolism ; Astrocytes - pathology ; Humans ; Hypertrophy - metabolism ; Hypertrophy - pathology ; Mice ; Mice, Transgenic ; Microglia - metabolism ; Microglia - pathology ; Microscopy, Electron ; Peptide Fragments - metabolism ; Plaque, Amyloid - metabolism ; Plaque, Amyloid - pathology ; Synapses - metabolism ; Synapses - pathology</subject><ispartof>Neurobiology of aging, 2001-01, Vol.22 (1), p.49</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c191t-5129570f64804c64d31f51ba1e9dae6435d0a2437199949da01d01216adc796a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11164276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wegiel, J</creatorcontrib><creatorcontrib>Wang, K C</creatorcontrib><creatorcontrib>Imaki, H</creatorcontrib><creatorcontrib>Rubenstein, R</creatorcontrib><creatorcontrib>Wronska, A</creatorcontrib><creatorcontrib>Osuchowski, M</creatorcontrib><creatorcontrib>Lipinski, W J</creatorcontrib><creatorcontrib>Walker, L C</creatorcontrib><creatorcontrib>LeVine, H</creatorcontrib><title>The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice</title><title>Neurobiology of aging</title><addtitle>Neurobiol Aging</addtitle><description>Ultrastructural reconstruction of 27 fibrillar plaques in different stages of formation and maturation was undertaken to characterize the development of fibrillar plaques in the brains of human APP(SW) transgenic mice (Tg2576). The study suggests that microglial cells are not engaged in Abeta removal and plaque degradation, but in contrast, are a driving force in plaque formation and development. Fibrillar Abeta deposition at the amyloid pole of microglial cells appears to initiate three types of neuropil response: degeneration of neurons, protective activation of astrocytes, and attraction and activation of microglial cells sustaining plaque growth. Enlargement of neuronal processes and synapses with accumulation of degenerated mitochondria, dense bodies, and Hirano-type bodies is the marker of toxic injury of neurons by fibrillar Abeta. Separation of amyloid cores from neurons and degradation of amyloid cores by cytoplasmic processes of hypertrophic astrocytes suggest the protective and defensive character of astrocytic response to fibrillar Abeta. The growth of cored plaque from a small plaque with one microglial cell with an amyloid star and a few dystrophic neurites to a large plaque formed by several dozen microglial cells seen in old mice is the effect of attraction and activation of microglial cells residing outside of the plaque perimeter. This mechanism of growth of plaques appears to be characteristic of cored plaques in transgenic mice. Other features in mouse microglial cells that are absent in human brain are clusters of vacuoles, probably of lysosomal origin. They evolve into circular cisternae and finally into large vacuoles filled with osmiophilic, amorphous material and bundles of fibrils that are poorly labeled with antibody to Abeta. Microglial cells appear to release large amounts of fibrillar Abeta and accumulate traces of fibrillar Abeta in a lysosomal pathway.</description><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloid beta-Protein Precursor - genetics</subject><subject>Amyloid beta-Protein Precursor - metabolism</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Animals</subject><subject>Astrocytes - metabolism</subject><subject>Astrocytes - pathology</subject><subject>Humans</subject><subject>Hypertrophy - metabolism</subject><subject>Hypertrophy - pathology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>Microscopy, Electron</subject><subject>Peptide Fragments - metabolism</subject><subject>Plaque, Amyloid - metabolism</subject><subject>Plaque, Amyloid - pathology</subject><subject>Synapses - metabolism</subject><subject>Synapses - pathology</subject><issn>0197-4580</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNo9j0tLAzEURrNQbK3-BCXLdjF670wmaZal-IKChVZcljtJpkYyMzWZCv33WnysPjgfHDiMXSHcIKC8XQFqlYlyCmOACQBOMYMTNvzHA3ae0jsAKKHkGRsgohS5kkNm12-Oxy443tW88SZ22-ApcONCSJxayyn1sTOH3iXuW177KvoQKPJdoI-94-6zC_ved-3x7SO1aetab_hsuRyvXidHp7tgpzWF5C5_d8Re7u_W88ds8fzwNJ8tMoMa-6zEXJcKaimmIIwUtsC6xIrQaUtOiqK0QLkoFGqtxTcDtIA5SrJGaUnFiF3_eHf7qnF2s4u-oXjY_OUWX8KcVak</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Wegiel, J</creator><creator>Wang, K C</creator><creator>Imaki, H</creator><creator>Rubenstein, R</creator><creator>Wronska, A</creator><creator>Osuchowski, M</creator><creator>Lipinski, W J</creator><creator>Walker, L C</creator><creator>LeVine, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200101</creationdate><title>The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice</title><author>Wegiel, J ; Wang, K C ; Imaki, H ; Rubenstein, R ; Wronska, A ; Osuchowski, M ; Lipinski, W J ; Walker, L C ; LeVine, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c191t-5129570f64804c64d31f51ba1e9dae6435d0a2437199949da01d01216adc796a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloid beta-Protein Precursor - genetics</topic><topic>Amyloid beta-Protein Precursor - metabolism</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Animals</topic><topic>Astrocytes - metabolism</topic><topic>Astrocytes - pathology</topic><topic>Humans</topic><topic>Hypertrophy - metabolism</topic><topic>Hypertrophy - pathology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>Microscopy, Electron</topic><topic>Peptide Fragments - metabolism</topic><topic>Plaque, Amyloid - metabolism</topic><topic>Plaque, Amyloid - pathology</topic><topic>Synapses - metabolism</topic><topic>Synapses - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wegiel, J</creatorcontrib><creatorcontrib>Wang, K C</creatorcontrib><creatorcontrib>Imaki, H</creatorcontrib><creatorcontrib>Rubenstein, R</creatorcontrib><creatorcontrib>Wronska, A</creatorcontrib><creatorcontrib>Osuchowski, M</creatorcontrib><creatorcontrib>Lipinski, W J</creatorcontrib><creatorcontrib>Walker, L C</creatorcontrib><creatorcontrib>LeVine, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Neurobiology of aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wegiel, J</au><au>Wang, K C</au><au>Imaki, H</au><au>Rubenstein, R</au><au>Wronska, A</au><au>Osuchowski, M</au><au>Lipinski, W J</au><au>Walker, L C</au><au>LeVine, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice</atitle><jtitle>Neurobiology of aging</jtitle><addtitle>Neurobiol Aging</addtitle><date>2001-01</date><risdate>2001</risdate><volume>22</volume><issue>1</issue><spage>49</spage><pages>49-</pages><issn>0197-4580</issn><abstract>Ultrastructural reconstruction of 27 fibrillar plaques in different stages of formation and maturation was undertaken to characterize the development of fibrillar plaques in the brains of human APP(SW) transgenic mice (Tg2576). The study suggests that microglial cells are not engaged in Abeta removal and plaque degradation, but in contrast, are a driving force in plaque formation and development. Fibrillar Abeta deposition at the amyloid pole of microglial cells appears to initiate three types of neuropil response: degeneration of neurons, protective activation of astrocytes, and attraction and activation of microglial cells sustaining plaque growth. Enlargement of neuronal processes and synapses with accumulation of degenerated mitochondria, dense bodies, and Hirano-type bodies is the marker of toxic injury of neurons by fibrillar Abeta. Separation of amyloid cores from neurons and degradation of amyloid cores by cytoplasmic processes of hypertrophic astrocytes suggest the protective and defensive character of astrocytic response to fibrillar Abeta. The growth of cored plaque from a small plaque with one microglial cell with an amyloid star and a few dystrophic neurites to a large plaque formed by several dozen microglial cells seen in old mice is the effect of attraction and activation of microglial cells residing outside of the plaque perimeter. This mechanism of growth of plaques appears to be characteristic of cored plaques in transgenic mice. Other features in mouse microglial cells that are absent in human brain are clusters of vacuoles, probably of lysosomal origin. They evolve into circular cisternae and finally into large vacuoles filled with osmiophilic, amorphous material and bundles of fibrils that are poorly labeled with antibody to Abeta. Microglial cells appear to release large amounts of fibrillar Abeta and accumulate traces of fibrillar Abeta in a lysosomal pathway.</abstract><cop>United States</cop><pmid>11164276</pmid><doi>10.1016/S0197-4580(00)00181-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 0197-4580
ispartof Neurobiology of aging, 2001-01, Vol.22 (1), p.49
issn 0197-4580
language eng
recordid cdi_pubmed_primary_11164276
source Elsevier
subjects Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Amyloid beta-Peptides - metabolism
Amyloid beta-Protein Precursor - genetics
Amyloid beta-Protein Precursor - metabolism
Amyloidosis - metabolism
Amyloidosis - pathology
Animals
Astrocytes - metabolism
Astrocytes - pathology
Humans
Hypertrophy - metabolism
Hypertrophy - pathology
Mice
Mice, Transgenic
Microglia - metabolism
Microglia - pathology
Microscopy, Electron
Peptide Fragments - metabolism
Plaque, Amyloid - metabolism
Plaque, Amyloid - pathology
Synapses - metabolism
Synapses - pathology
title The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A11%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20microglial%20cells%20and%20astrocytes%20in%20fibrillar%20plaque%20evolution%20in%20transgenic%20APP(SW)%20mice&rft.jtitle=Neurobiology%20of%20aging&rft.au=Wegiel,%20J&rft.date=2001-01&rft.volume=22&rft.issue=1&rft.spage=49&rft.pages=49-&rft.issn=0197-4580&rft_id=info:doi/10.1016/S0197-4580(00)00181-0&rft_dat=%3Cpubmed%3E11164276%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c191t-5129570f64804c64d31f51ba1e9dae6435d0a2437199949da01d01216adc796a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11164276&rfr_iscdi=true